Mediwelcome Healthcare Management & Technology Inc. (Mediwelcome) reported revenue of RMB 230.91 million for the six months ended 30 June 2026, up 81.7% from the prior-year period. The group swung to a net profit of RMB 17.84 million, reversing a RMB 4.09 million loss in 2025.
Double-digit margin expansion and AI-led mix shift • Gross profit rose to RMB 69.74 million, lifting the gross margin to 30.2%, a 13.1-percentage-point improvement year on year. • Revenue from the AI Digital Intelligence Platforms segment reached RMB 194.08 million, more than tripling (+2.05-times) year on year and accounting for 84.1% of total turnover. Within this segment, Digital Marketing & Sales Solutions contributed RMB 122.81 million (+770.9%), Intelligent Research Platform RMB 63.18 million (+32.5%), Patient Follow-up & Management Platform RMB 6.68 million (+509.1%), and Internet Hospital Services RMB 1.42 million (+75.0%). • Traditional Medical Conference Services and Marketing Strategy & Consulting fell 59.9% and 31.9%, respectively, reflecting the business’s migration to digital offerings.
Cost dynamics and investment in technology • Cost of sales rose 53.1% to RMB 161.17 million, trailing revenue growth and supporting margin expansion. • R&D expenditure jumped 373.0% to RMB 29.77 million, driven by continued development of AI vertical models, digital marketing solutions and intelligent medical platforms. • Administrative expenses declined 8.0% to RMB 17.21 million following office rationalisation, while selling expenses increased 9.3% to RMB 8.18 million amid expanded marketing activities.
Balance-sheet movements • Cash and bank balances grew 39.5% to RMB 138.54 million. • Net current liabilities totalled RMB 47.35 million versus net current assets of RMB 73.53 million at end-2025, mainly due to the acquisition consideration payable for MediAI Technology Development Limited. • Interest-bearing bank borrowings stood at RMB 60.59 million, and the gearing ratio eased to 33.6% from 45.2% at year-end 2025.
Strategic transactions • On 23 June 2026, Mediwelcome completed the 100% acquisition of MediAI, adding RMB 159.06 million of intangible assets and RMB 71.78 million of goodwill to the balance sheet. • A placing of up to 65 million shares at HK$1.50 each, announced on 30 March 2026, remained in progress at period-end; expected net proceeds are approximately HK$92.34 million, earmarked primarily for the MediAI purchase.
Operational metrics • Registered doctor users on the digital medical platform reached 837,975. • The group facilitated 131,494 online doctor education events, 154,451 online patient education events and produced 190,528 medical videos generating 22.09 million views.
No interim dividend was declared for the period.
Comments